Adialante
PrivateLast Round
Seed
Jul 1, 2026
Total Funding Raised
$3.47M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Adialante operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was an Accelerator round in April 2026.
Adialante is a medical device company that develops affordable, compact, and mobile MRI systems designed to make cancer screening more accessible.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adialante Comparables
Compare Adialante with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepSpin | 80% | |
| PhysioMRI Tech S.L. | 77% | |
| Promaxo | 77% |
For institutional investors. Book with your work email.
Adialante Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2026 | ||||
| Accelerator | Apr 23, 2026 | ||||
| Grant | Jun 19, 2025 | ||||
| Seed | Aug 30, 2024 | ||||
| Grant | Jun 30, 2024 | ||||
Grant | Dec 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adialante Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Accelerator |
| Walleye Tank | Grant |
| America's Seed Fund | Grant |
| Y Combinator | Accelerator |
| University of Minnesota | Seed, Grant |
| Fogarty Innovation | Seed, Accelerator |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles increased to 4, representing 44% of headcount.
- Aug 24, 2026
Open roles increased to 3, 43% of headcount.
For institutional investors. Book with your work email.
Adialante Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adialante's valuation, stock price, and market status.
Is Adialante a public or private company?
Adialante is a private company.
What is the current stock price of Adialante?
Adialante is a private company, so its shares have no public market price. Caplight tracks Adialante's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adialante worth (valuation)?
Valuation information for Adialante is not publicly available.
Can I buy Adialante stock?
Adialante shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adialante's last funding round?
Adialante's most recent funding round was Seed on July 1, 2026.
Who are the main investors in Adialante?
Key investors in Adialante include Y Combinator, University of Minnesota, Fogarty Innovation, National Science Foundation.
Will Adialante IPO soon?
No public IPO plans have been announced for Adialante.
How can I track Adialante secondary market activity?
Caplight tracks bids, offers, and trades in Adialante's shares on secondary markets.